ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

OPTI Optibiotix Health Plc

18.25
0.00 (0.00%)
31 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Optibiotix Health Plc LSE:OPTI London Ordinary Share GB00BP0RTP38 ORD 2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 18.25 17.50 19.00 18.25 18.25 18.25 44,934 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Noncomml Resh Organizations 457k 2.59M 0.0284 6.43 16.64M
Optibiotix Health Plc is listed in the Noncomml Resh Organizations sector of the London Stock Exchange with ticker OPTI. The last closing price for Optibiotix Health was 18.25p. Over the last year, Optibiotix Health shares have traded in a share price range of 5.75p to 43.50p.

Optibiotix Health currently has 91,190,661 shares in issue. The market capitalisation of Optibiotix Health is £16.64 million. Optibiotix Health has a price to earnings ratio (PE ratio) of 6.43.

Optibiotix Health Share Discussion Threads

Showing 38426 to 38449 of 147675 messages
Chat Pages: Latest  1539  1538  1537  1536  1535  1534  1533  1532  1531  1530  1529  1528  Older
DateSubjectAuthorDiscuss
07/6/2018
12:06
Gut mania’ has put consumers around the world ahead of the science. Despite the ever-increasing number of probiotic supplements, foods, and beverages, consumers are confused about what they are, how they work, and why they should take them. The science of probiotics demands precision, accountability, and efficacy. We combine human clinical research, proprietary technology, and innovations in biofermentation, formulation, stabilization, and testing, to set a new standard for bacteria.

Mumbo jumbo

“The science of probiotics demands precision, accountability, and efficacy”

Ok, lets see how they get there and the results of their claims. Efficacy? Show the proof that we can understand and see. Are there humans walking around that have improved health from these products? If there are, then let us know who and where they are.

rayrac
07/6/2018
11:47
I reckon as share holders we should get a decent discount....bring it up at the AGM?
glennrcharles
07/6/2018
11:40
I’m sorry Nobby, but if it has an effect on the body as they claim, then I’d want to see trials that validated the product...on humans. The only trial I’ve seen, claims no more benefit than Benecol for cholesterol.

And far more expensive!

rayrac
07/6/2018
11:33
>> rayrac

You are dong yourself a disservice by posting such nonsense. There is no need to do Pharma like clinical trials for such a product. If they did, the cost of the trials would be exorbitant and the product would have to be priced very high.

It is just a ridiculous thing to suggest.....

Nobby

nobbygnome
07/6/2018
11:33
That’s all youve got to say ...mate?

Like the product mate, you’re useless. ;)

rayrac
07/6/2018
11:26
I see Mr UKOG's here
Hows things looking over there Mate?

judijudi
07/6/2018
11:19
Our Daily Synbiotic was developed for systemic benefits beyond digestive health—the first in a pipeline of scientifically-validated, next-generation products.


Phase 1/2/3 trials on the human body? Of course not, its notaffective enough to bother real scientists in testing it!

And what will this jar of capsules cost here in this country? £50 month?

A so called health product like the rest of health care products...useless.

rayrac
07/6/2018
10:16
Only available in the US (International shipping to come).

But, they need to make this available to directly purchase in the UK and EU....message sent to them!

undertaker
07/6/2018
10:16
Does look great, but of course and yet again, no impact on share price.
I do think Opti need to up their PR game.

mouse20
07/6/2018
10:06
The SEED product looks amazing.. the collective brain power used to create the products are incredibly impressive. I was a bit concerned people may be put off by having to take 3 capsules per day, but thankfully you can take them all together in the morning!
trotterstrading
07/6/2018
10:04
Yes extra with shipping though
trotterstrading
07/6/2018
10:02
Go on to the website and see if you can subscribe?
toadhall1
07/6/2018
09:28
will that Seed product be available to buy in the UK?
I want some for myself!

undertaker
07/6/2018
09:00
We will soon be into H2 when Galenicum Special Ingredients will be launching Cardiocare.
parob
07/6/2018
08:54
Possibly AIM working. OPTI seems to have a price.
m4rtinu
07/6/2018
08:41
I was thinking I was doing well this morning with nothing in the red too :)
woodaldo
07/6/2018
08:39
Thanks, thought my iPad gone iffy....
joyjoy13
07/6/2018
08:27
No point ramping today, LSE has crashed. x
incanus
07/6/2018
08:26
For those of you wondering why no price move, there is a glitch with the market, delayed opening. Must be using TSB's IT team.
woodaldo
07/6/2018
08:22
I liked the fact they have an article in VOGUE simply because it makes a change from the usual scientific research magazines, New Scientist etc etc. It’s getting out there in the general public, which is key in my humble opinion!
Just my thoughts and observations....
No ramping required!

joyjoy13
07/6/2018
08:15
LP-LDL is key to the Seed symbiotic. Without it it would be like putting unleaded in your diesel.
elrico
07/6/2018
08:12
Note that in the Coveteur article LPLDL gets a specific mention.That would not happen unless it is a 'must have' in the Seed mix.
aspex
07/6/2018
07:49
This should be very big news for OPTI. The criticism of the nay sayers is that there are no revenues from all the progress made so far in deals. Here we have tangible evidence that revenues are beginning to flow!

But no doubt the price will be a damp squib today. Sometimes I despair of AIM....

Nobby

nobbygnome
07/6/2018
07:39
Good article Parob. However...
'Shelfability'! wtf.

dire cons
Chat Pages: Latest  1539  1538  1537  1536  1535  1534  1533  1532  1531  1530  1529  1528  Older